Moradi Yousef, Baradaran Hamid Reza, Djalalinia Shirin, Chinekesh Ahdieh, Khamseh Mohamad Ebrahim, Dastoorpoor Maryam, Sioofy-Khojine Amir-Babak, Saed Lotfolah, Qorbani Mostafa
Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Iran.
Diabetes Metab Syndr. 2019 May-Jun;13(3):2300-2312. doi: 10.1016/j.dsx.2019.05.018. Epub 2019 May 23.
Complications among patients with type 2 diabetes mellitus (T2DM) have increased dramatically through two past decades. Thus, the aim of this updated systematic review and meta-analysis was to estimate the pooled prevalence of T2DM complications in Iranian patients. Using Medical Subject Headings terms, Emtree, and related equal Persian key words, international databases including PubMed, ISI/WOS, Scopus, Iran Medex, SID, Magiran, Irandoc, Medlib, domestic databases were searched from January 1990 till January 2018 reporting prevalence of any complications of type 2 diabetes in Iran. All the keywords were searched electronically by two Boolean operators through the explained search strategy, separately. Relevant additional articles were identified from the lists of the retrieved articles. Random and fixed effect meta-analysis was used to estimate the pooled prevalence of complications in Iranian patients with T2DM. Through searching steps, among 1238 publications retrieved from literature search, finally 45 studies met the inclusion criteria for meta-analysis, with number of 30679 participants. According to random effect, the estimated pooled prevalence of diabetic foot ulcer, cardiovascular disease, retinopathy, neuropathy and nephropathy in Iranian patients with T2DM were 3%(95% CI: 1-5%), 33%(95% CI: 16-49%), 36%(95% CI: 27-45%), 38% (95% CI: 14-63%), and 43% (95% CI: 27-60%), respectively. This updated meta-analysis shows that prevalence of major microvascular complications of T2DM in Iran is high. Our findings provide practical evidence for better planning and clinical decision making.
在过去二十年中,2型糖尿病(T2DM)患者的并发症急剧增加。因此,本次更新的系统评价和荟萃分析的目的是估计伊朗患者中T2DM并发症的合并患病率。使用医学主题词、Emtree以及相关的波斯文同义词,从1990年1月至2018年1月检索包括PubMed、ISI/WOS、Scopus、伊朗医学数据库、SID、Magiran、Irandoc、Medlib在内的国际数据库以及国内数据库,以查找报告伊朗2型糖尿病任何并发症患病率的研究。所有关键词均通过两种布尔运算符,按照所解释的检索策略分别进行电子检索。从检索到的文章列表中识别出相关的其他文章。采用随机效应和固定效应荟萃分析来估计伊朗T2DM患者并发症的合并患病率。通过检索步骤,在从文献检索中获取的1238篇出版物中,最终有45项研究符合荟萃分析的纳入标准,涉及30679名参与者。根据随机效应,伊朗T2DM患者中糖尿病足溃疡、心血管疾病、视网膜病变、神经病变和肾病的估计合并患病率分别为3%(95%CI:1-5%)、33%(95%CI:16-49%)、36%(95%CI:27-45%)、38%(95%CI:14-63%)和43%(95%CI:27-60%)。本次更新的荟萃分析表明,伊朗T2DM主要微血管并发症的患病率很高。我们的研究结果为更好地规划和临床决策提供了实际证据。